MEDICINE MAN TECHNOLOGIES INC News

Benchmark: Reiterates Medicine Man Technologies (SHWZ.US) rating, adjusted from buy to buy rating, target price $2.50.

Benchmark: Reiterates Medicine Man Technologies (SHWZ.US) rating, adjusted from buy to buy rating, target price $2.50.

Zhitong FinanceMay 16 09:02

Benchmark Reiterates Buy on Medicine Man Technologies, Maintains $2.5 Price Target

Benchmark analyst Mike Hickey reiterates Medicine Man Technologies with a Buy and maintains $2.5 price target.

Analyst UpgradesMay 16 09:00

Medicine Man Technologies Inc (SHWZ) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...

Yahoo FinanceMay 16 02:09

Earnings Call Summary | MEDICINE MAN TECHNOLOGIES INC(SHWZ.US) Q1 2024 Earnings Conference

The following is a summary of the Medicine Man Technologies, Inc. (SHWZ) Q1 2024 Earnings Call Transcript:Financial Performance:Medicine Man Technologies reported Q1 2024 revenue of $41.6 million, a 4

Futu NewsMay 15 22:53 · Conference Call

Schwazze's Q1 2024 Financial Results: Takes A Hit In Colorado, Overall Cannabis Sales Up By 9%

Medicine Man Technologies, Inc., operating as Schwazze (OTC:SHWZ), announced its financial results for the first quarter ended March 31, 2024. Schwazze's interim CEO, Forrest Hoffmaster, commented on

BenzingaMay 15 17:14

Medicine Man Technologies Q1 2024 GAAP EPS $(0.24) Misses $(0.16) Estimate, Sales $41.601M Beat $39.834M Estimate

Medicine Man Technologies (OTC:SHWZ) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.16) by 50 percent. This is a 300 percent decrease over losses of

BenzingaMay 15 15:12

Press Release: Schwazze Announces First Quarter 2024 Financial Results

Schwazze Announces First Quarter 2024 Financial Results Canada NewsWire DENVER, May 15, 2024 Schwazze Management to Host Conference Call Today at 5:00 p.m. Eastern Time DENVER, May 15, 2024 /CNW/

Dow JonesMay 15 15:05

Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 P.m. ET

DENVER, April 29, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, Ma

PR NewswireApr 29 15:30

Marijuana Investors Bet Big On Long-Term Growth Over Short-Term Earnings As Market Value Rises By 39%

Recent data from the Viridian Cannabis Deal Tracker highlights significant changes in the valuation multiples of major multi-state operators (MSOs) in the cannabis sector. The Viridian Cannabis Deal T

BenzingaApr 15 18:53

MEDICINE MAN TECHNOLOGIES INC(SHWZ.US) Officer Buys US$105 in Common Stock

$MEDICINE MAN TECHNOLOGIES INC(SHWZ.US)$ Officer Pabon Daniel purchased 150 shares of common stock on Apr 11, 2024 at an average price of $0.7 for a total value of $105.Source: Announcement What is st

Futu NewsApr 15 18:18

Cannabis Market's Trading Volume Surges Up 292%, Viridian Capital Highlights Mixed Liquidity

A recent analysis by Viridian Capital Advisors provides intriguing insights into the liquidity of cannabis companies, indicating both advancements and setbacks in the sector. Despite an overall increa

BenzingaApr 11 12:17

Medicine Man Technologies GAAP EPS of -$0.43, Revenue of $43.3M Misses by $2.17M

Seeking AlphaMar 28 10:47

Schwazze Reports Slight Revenue Drop In Q4 2023 Amid 'Fierce' Competition In Cannabis Retail Sector

Medicine Man Technologies, Inc. (OTC:SHWZ), operating as Schwazze, announced its financial and operational results on Thursday for the fourth quarter and full year ended Dec. 31, 2023."This past year,

BenzingaMar 28 10:42

Medicine Man Technologies Is Maintained at Buy by Benchmark

Medicine Man Technologies Is Maintained at Buy by Benchmark

Dow JonesMar 28 10:25

Benchmark Maintains Buy on Medicine Man Technologies, Lowers Price Target to $2.5

Benchmark analyst Mike Hickey maintains Medicine Man Technologies with a Buy and lowers the price target from $3 to $2.5.

Analyst UpgradesMar 28 10:15

Medicine Man Technologies Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/28/2024 237.38% Benchmark $3 → $2.5 Maintains Buy 03/30/2023 304.86% Benchmark → $3 Reiterates → Buy 12

BenzingaMar 28 10:13

Earnings Call Summary | MEDICINE MAN TECHNOLOGIES INC(SHWZ.US) Q4 2023 Earnings Conference

The following is a summary of the Medicine Man Technologies, Inc. (SHWZ) Q4 2023 Earnings Call Transcript:Financial Performance:Medicine Man Technologies (Schwazze) reported Q4 revenue of $43.3 millio

Futu NewsMar 27 21:01 · Conference Call

Medicine Man Technologies Q4 EPS $(0.38) Misses $(0.13) Estimate, Sales $43.33M Miss $45.47M Estimate

Medicine Man Technologies (OTC:SHWZ) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.13) by 192.31 percent. This is a 22.58 percent decrease over loss

BenzingaMar 27 15:50

Earnings Flash (SHWZ) SCHWAZZE Reports Q4 Revenue $43.3M

04:14 PM EDT, 03/27/2024 (MT Newswires) -- Earnings Flash (SHWZ) SCHWAZZE Reports Q4 Revenue $43.3M

MT NewswiresMar 27 15:14

Press Release: Schwazze Announces Fourth Quarter and Full Year 2023 Financial Results

Schwazze Announces Fourth Quarter and Full Year 2023 Financial Results Canada NewsWire DENVER, March 27, 2024 FY 2023 Revenue of $172.4 Million; Income from Operations of $3.3 Million; Adjusted EBI

Dow JonesMar 27 15:05